Perlmutter Cancer Center at NYU Langone Hospital - Long Island is a clinical research site located in Mineola, New York, United States 11501.
Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.
Perlmutter Cancer Center at NYU Langone Hospital - Long Island has participated in 19 clinical trials with 16 currently active.
Therapeutic areas: Non-Small Cell Lung Cancer, Uterine Neoplasms, Uterine Cervical Neoplasms.
Sponsors: Bristol-Myers Squibb, Seagen, a wholly owned subsidiary of Pfizer, Eli Lilly and Company.
Trust Score: 80/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Perlmutter Cancer Center at NYU Langone Hospital - Long Island has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Perlmutter Cancer Center at NYU Langone Hospital - Long Island has 19 clinical trials on record, with 16 currently active. Their work covers Non-Small Cell Lung Cancer, Uterine Neoplasms, Uterine Cervical Neoplasms.
Yes — Perlmutter Cancer Center at NYU Langone Hospital - Long Island holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.